Current and historical daily PE Ratio for Agilent Technologies Inc (
LTS:0HAV
) from 2018 to May 12 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Agilent Technologies stock (LTS:0HAV) PE ratio as of May 12 2024 is 35.66.
More Details
Agilent Technologies Inc (LTS:0HAV) PE Ratio (TTM) Chart
Agilent Technologies Inc (LTS:0HAV) PE Ratio (TTM) Historical Data
View and export this data going back to 2018. Start your Free Trial
Total 1251
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Agilent Technologies PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-12 | 35.6 | 2024-03-11 | 35.1 |
| 2024-05-10 | 35.6 | 2024-03-08 | 35.8 |
| 2024-05-09 | 34.4 | 2024-03-07 | 35.5 |
| 2024-05-08 | 33.7 | 2024-03-06 | 34.7 |
| 2024-05-07 | 33.7 | 2024-03-05 | 34.4 |
| 2024-05-06 | 33.4 | 2024-03-04 | 34.0 |
| 2024-05-03 | 33.4 | 2024-03-01 | 33.0 |
| 2024-05-02 | 32.8 | 2024-02-29 | 32.7 |
| 2024-05-01 | 32.9 | 2024-02-28 | 32.6 |
| 2024-04-30 | 32.9 | 2024-02-27 | 31.6 |
| 2024-04-29 | 33.3 | 2024-02-26 | 31.3 |
| 2024-04-26 | 32.5 | 2024-02-23 | 31.6 |
| 2024-04-25 | 32.4 | 2024-02-22 | 31.1 |
| 2024-04-24 | 32.6 | 2024-02-21 | 32.0 |
| 2024-04-23 | 33.3 | 2024-02-20 | 32.1 |
| 2024-04-22 | 32.1 | 2024-02-19 | 32.4 |
| 2024-04-19 | 31.8 | 2024-02-16 | 32.4 |
| 2024-04-18 | 31.9 | 2024-02-15 | 32.2 |
| 2024-04-17 | 32.0 | 2024-02-14 | 31.2 |
| 2024-04-16 | 32.8 | 2024-02-13 | 30.8 |
| 2024-04-15 | 33.2 | 2024-02-12 | 31.4 |
| 2024-04-12 | 33.7 | 2024-02-09 | 31.6 |
| 2024-04-11 | 34.6 | 2024-02-08 | 31.7 |
| 2024-04-10 | 34.4 | 2024-02-07 | 31.7 |
| 2024-04-09 | 34.9 | 2024-02-06 | 32.3 |
| 2024-04-08 | 34.5 | 2024-02-05 | 31.9 |
| 2024-04-05 | 34.5 | 2024-02-02 | 31.6 |
| 2024-04-04 | 34.5 | 2024-02-01 | 31.5 |
| 2024-04-03 | 34.4 | 2024-01-31 | 31.5 |
| 2024-04-02 | 34.2 | 2024-01-30 | 31.9 |
| 2024-04-01 | 34.9 | 2024-01-29 | 31.4 |
| 2024-03-29 | 34.9 | 2024-01-26 | 31.2 |
| 2024-03-28 | 34.9 | 2024-01-25 | 30.9 |
| 2024-03-27 | 34.9 | 2024-01-24 | 30.9 |
| 2024-03-26 | 34.5 | 2024-01-23 | 31.1 |
| 2024-03-25 | 34.6 | 2024-01-22 | 31.4 |
| 2024-03-22 | 35.0 | 2024-01-19 | 31.2 |
| 2024-03-21 | 35.7 | 2024-01-18 | 30.9 |
| 2024-03-20 | 34.9 | 2024-01-17 | 30.1 |
| 2024-03-19 | 35.0 | 2024-01-16 | 31.0 |
| 2024-03-18 | 35.1 | 2024-01-15 | 31.1 |
| 2024-03-15 | 35.2 | 2024-01-12 | 31.1 |
| 2024-03-14 | 34.6 | 2024-01-11 | 30.8 |
| 2024-03-13 | 35.3 | 2024-01-10 | 30.8 |
| 2024-03-12 | 35.1 | 2024-01-09 | 31.3 |
Agilent Technologies Inc (LTS:0HAV) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Agilent Technologies Inc
NAICS : 334516
SIC : 3825
ISIN : US00846U1016
Description
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers